ecancermedicalscience

Review

Anal canal cancer in Brazil: why should we pay more attention to the epidemiology of this rare disease?

7 May 2020
Mauro DS Donadio, Rachel P Riechelmann

Anal canal cancer is one of the human papilloma virus (HPV)-associated diseases with increasing incidence. High-risk sexual behaviour and the resurgence of human immunodeficiency virus (HIV) infection, associated with low HPV vaccine coverage, are risk factors for the increased incidence of this cancer. In this paper, the authors point out pertinent questions regarding the greater exposure of the population to some risk factors and discuss the latest epidemiological data of these factors, particularly those of concern to emerging countries like Brazil. The authors also discuss policies adopted that have not been successful to combat the HIV and HPV rise and that have direct consequences on the incidence of anal canal cancer.

Related Articles

Jade Tso, Mustafa Al-Qaraghli, Susana Galeas, Mustafa Faleh Abidalhassan, Cameron E Gaskill
Kiara S Berumen, Alberto Sánchez-Navarro, Andrea Velázquez, Manuel Solano, Francisco Anaya, Gustavo Rosales, Alexandra Díaz, Johana Jazer, Kathia Zamudio, Susana Suder, Marisol Quintero, Adriana González-Martínez, Luis A García
Samuel Santiago Parra Giraldo, Rut Amparo Vergara López, Haydee De La Hoz-Herazo, Enrique Carlos Ruiz Pla, Brayan Bayona-Pacheco, Juan Jose Espitia De La Hoz
Soumitra Shankar Datta, Heena Sheth, Sharmili Ghosh, Srijan Das, Jigeesha Ghosh, Dishari Choudhury, Arnab Mukherjee, Soumita Ghose, Romy Biswas, Maria Castrillo Gil, Carlos Andres Gamboa Alfaro, Mary Guevara, Danny Burke, Sujit Sarkhel, Jai Ranjan Ram
Shama Pandey, Bishnu Dutta Paudel, Bibek Acharya, Sandhya Chapagain Acharya, Ambuj Karn, Saugat Poudyal, Manish Poudel, Pradeep Thapa, Jasmine Gurung, Ramila Shilpakar
Diego Rodrigues Mendonça e Silva, Max Moura de Oliveira, Gisele Aparecida Fernandes, Maria Paula Curado